GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kineta Inc (STU:J75) » Definitions » Interest Paid

Kineta (STU:J75) Interest Paid


View and export this data going back to 2017. Start your Free Trial

What is Kineta Interest Paid?

Interest Paid only applicable to companies reporting Cash Flow from Operations in direct method.


Kineta (STU:J75) Business Description

Traded in Other Exchanges
Address
219 Terry Avenue North, Suite 300, Seattle, WA, USA, 98109
Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.